Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference18 articles.
1. Van Dussen L, Biegstraaten M, Hollack CE, Dijkgraaf MG. Cost effectiveness of enzyme replacement therapy for type 1 gaucher disease. Orphanet J Rare Dis. 2014;9:51.
2. Pastores GM, Hughes DA, Gaucher Disease. 2000 Jul 27 [Updated 2023 Mar 9]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1269/.
3. Muranjan M, Karande S. Enzyme replacement therapy in India: lessons and insights. J Postgrad Med. 2018;64:195–9.
4. Schuller Y, Hollak CE, Biegstraaten M. The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review. Orphanet J Rare Dis. 2015;10:92.
5. Ministry of Health & Family Welfare. National Policy for Rare Diseases, 2021. Available at: https://main.mohfw.gov.in/sites/default/files/Final%20NPRD%2 C%202021.pdf. Accessed on 20 Sept 2021.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献